MOPA — Medical Oncology Prior Authorization
0.1.1-snapshot-080926 - snapshot-080926 United States of America flag

MOPA — Medical Oncology Prior Authorization - Local Development build (v0.1.1-snapshot-080926) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

: Example: Pegfilgrastim MedicationRequest (ddAC→T regimen, draft)

Page standards status: Informative

Raw xml | Download


<MedicationRequest xmlns="http://hl7.org/fhir">
  <id value="PegfilgrastimMedRequestDDACT"/>
  <meta>
    <profile
             value="http://hl7.org/fhir/us/mcode/StructureDefinition/mcode-cancer-related-medication-request"/>
  </meta>
  <language value="en"/>
  <text>
    <status value="generated"/>
    <div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: MedicationRequest PegfilgrastimMedRequestDDACT</b></p><a name="PegfilgrastimMedRequestDDACT"> </a><a name="hcPegfilgrastimMedRequestDDACT"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="http://hl7.org/fhir/us/mcode/STU4/StructureDefinition-mcode-cancer-related-medication-request.html">Cancer-Related Medication Request Profile</a></p></div><p><b>status</b>: Draft</p><p><b>intent</b>: Order</p><p><b>medication</b>: <span title="Codes:{http://www.nlm.nih.gov/research/umls/rxnorm 338036}">pegfilgrastim</span></p><p><b>subject</b>: <a href="Patient-MOPAPatientExample.html">Jane Smith (official) Female, DoB: 1968-04-15 ( http://hospital.example.org/patients#MRN-78432)</a></p><p><b>requester</b>: <a href="Practitioner-MOPAOncologistExample.html">Practitioner Maria Lopez (official)</a></p><p><b>reasonReference</b>: <a href="Condition-MOPABreastCancerConditionExample.html">Condition Malignant neoplasm of breast</a></p><h3>DosageInstructions</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Text</b></td></tr><tr><td style="display: none">*</td><td>6 mg subcutaneous day 2 of each 14-day cycle</td></tr></table></div>
  </text>
  <status value="draft"/>
  <intent value="order"/>
  <medicationCodeableConcept>
    <coding>
      <system value="http://www.nlm.nih.gov/research/umls/rxnorm"/>
      <code value="338036"/>
      <display value="pegfilgrastim"/>
    </coding>
  </medicationCodeableConcept>
  <subject>🔗 
    <reference value="Patient/MOPAPatientExample"/>
  </subject>
  <requester>🔗 
    <reference value="Practitioner/MOPAOncologistExample"/>
  </requester>
  <reasonReference>🔗 
    <reference value="Condition/MOPABreastCancerConditionExample"/>
  </reasonReference>
  <dosageInstruction>
    <text value="6 mg subcutaneous day 2 of each 14-day cycle"/>
  </dosageInstruction>
</MedicationRequest>